BioTime and Subsidiary LifeMap Sciences Announce Release of Enhanced LifeMap BioReagents™Portal Offering Additional PureStem™ Human Progenitor Cells Including Those for Diabetes Research "The ...

AANE LifeMAP has a team of dedicated coaches with master's and doctorate degrees, bringing decades of person-centered, holistic experience to the table, along with a profound understanding of ...

LifeMap Sciences will be the principle marketing ... currently being developed for the detection of cancer in blood samples. ReCyte Therapeutics, Inc. is developing applications of BioTime's ...

LifeMap clients and partners include dozens ... currently being developed for the detection of cancer in blood samples. ReCyte Therapeutics, Inc. is developing applications of BioTime's ...

ALAMEDA, Calif.--(BUSINESS WIRE)-- LifeMap Sciences, Inc., a subsidiary of BioTime, Inc. (NYSE MKT: BTX), announced today that the LifeMap Discovery™ product has been documented in a published ...

The ratings reflect LifeMap’s balance sheet strength, which AM Best assesses as strongest, as well as its marginal operating performance, limited business profile, appropriate enterprise risk ...

In the first third-party post to Apple's ResearchKit blog, mobile health provider LifeMap Solutions reports seeing high rates of consent and participation due in large part to iOS and iPhone app ...

The outlooks of these ratings are stable. These rating actions follow the Jan. 3, 2022 announcement that LifeMap’s ultimate parent, Cambia Health Solutions, Inc. (Cambia), has finalized its ...

PORTLAND, Ore., Oct. 10, 2012 /PRNewswire/ -- LifeMap Assurance Company is pleased to announce the addition or promotion of eight staff to the company's leadership team. These individuals will ...